These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7783385)

  • 1. [A case of chronic active hepatitis C presenting heart failure during interferon alpha 2 alpha therapy].
    Shinagawa J; Inagaki Y; Suzuki M; Atsukawa K; Yonei Y; Tsukada N; Miyamoto K; Suzuki O; Kawamura Y; Kiryu Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 May; 92(5):899-903. PubMed ID: 7783385
    [No Abstract]   [Full Text] [Related]  

  • 2. Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Núñez M; Miralles ES; de las Heras ME; Ledo A
    J Dermatol; 1995 Jun; 22(6):461-2. PubMed ID: 7650248
    [No Abstract]   [Full Text] [Related]  

  • 3. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S; Di Perri G; Garofano T; Cosco L; Concia E; Ferraro T; Bassetti D
    Lancet; 1989 Oct; 2(8668):926. PubMed ID: 2571851
    [No Abstract]   [Full Text] [Related]  

  • 4. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
    Fukumoto Y; Shigemitsu T; Kajii N; Omura R; Harada T; Okita K
    Intern Med; 1994 Oct; 33(10):637-40. PubMed ID: 7827383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon induced IBD-like acute colitis--two cases of patients with chronic active hepatitis].
    Yamamoto Y; Sakatani N; Yano S; Kou K; Ochi S; Yoshida Y; Fujimoto R; Ohno K; Sawai S
    Nihon Shokakibyo Gakkai Zasshi; 1995 Sep; 92(9):1293-6. PubMed ID: 7474487
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection.
    Schlesinger TE; Camisa C; Gay JD; Bergfeld WF
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1023-5. PubMed ID: 9204077
    [No Abstract]   [Full Text] [Related]  

  • 7. Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C.
    Tada H; Saitoh S; Nakagawa Y; Hirana H; Morimoto M; Shima T; Shimamoto K; Okanoue T; Kashima K
    J Gastroenterol; 1996 Aug; 31(4):582-4. PubMed ID: 8844482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulomatous hepatitis in a patient with chronic hepatitis C treated with interferon-alpha.
    Veerabagu MP; Finkelstein SD; Rabinovitz M
    Dig Dis Sci; 1997 Jul; 42(7):1445-8. PubMed ID: 9246044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C. A case report.
    Teragawa H; Hondo T; Amano H; Watanabe H; Ohe H; Hattori N; Watanabe Y; Hino F; Ohbayashi M
    Jpn Heart J; 1996 Jan; 37(1):137-42. PubMed ID: 8632622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Esophageal candidiasis during interferon therapy for chronic viral hepatitis C].
    Prignet JM; Galzin M; Demarquay JF; Raynard B; Louvety S; Künkel D
    Gastroenterol Clin Biol; 1994; 18(8-9):796-7. PubMed ID: 7875459
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum complement cold activation is vanished by the interferon therapy for chronic active hepatitis C patients].
    Ando B; Shimohashi N; Sumii T; Sasaki N; Furudera S; Tanaka E
    Nihon Shokakibyo Gakkai Zasshi; 1995 Oct; 92(10):1811. PubMed ID: 7474477
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of hepatitis B and C with interferon-alpha can induce or aggravate psoriasis].
    Cervoni JP; Serfaty L; Picard O; Imbert JC; Poupon R
    Gastroenterol Clin Biol; 1995 Mar; 19(3):324-5. PubMed ID: 7781955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoimmune thrombocytopenic purpura after treatment of chronic viral hepatitis C with interferon].
    Maïga MY; Oberti F; Foussard C; Calès P
    Gastroenterol Clin Biol; 1995; 19(8-9):739-40. PubMed ID: 8522132
    [No Abstract]   [Full Text] [Related]  

  • 14. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C.
    Barreca T; Corsini G; Franceschini R; Gambini C; Garibaldi A; Rolandi E
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):367-8. PubMed ID: 7600144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.
    Khan HA; Khawaja FI; Mahrous AR
    Am J Gastroenterol; 1996 Apr; 91(4):821-2. PubMed ID: 8677971
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of chronic hepatitis C with recombinant interferon alfa.
    Chen YK; Bala K
    West J Med; 1992 Jan; 156(1):72. PubMed ID: 1734608
    [No Abstract]   [Full Text] [Related]  

  • 17. [An autopsied case of interstitial and infectious pneumonia appeared during interferon treatment for C-type chronic active hepatitis].
    Motegi K; Yamada S; Saruya S; Hayashi T; Otani N
    Nihon Shokakibyo Gakkai Zasshi; 1994 Mar; 91(3):350-4. PubMed ID: 8145375
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte subpopulations as factors predicting clinical response to interferon in hepatitis C virus-related chronic active hepatitis.
    Guadagnino V; Caroleo B; Izzi A; De Rosa G; D'Amelio R
    Infection; 1995; 23(3):189-90. PubMed ID: 7499011
    [No Abstract]   [Full Text] [Related]  

  • 20. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Protzer U; Ochsendorf FR; Leopolder-Ochsendorf A; Holtermüller KH
    Gastroenterology; 1993 Mar; 104(3):903-5. PubMed ID: 8440441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.